Kofnix Pediatric Drops 5 mg/ml Uses, Dosage, Side Effects and more

Kofnix Pediatric Drops 5 mg/ml Uses, Dosage, Side Effects, Food Interaction and all others data.

Table Of contents

• Kofnix Pediatric Drops 5 mg/ml
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Kofnix Pediatric Drops 5 mg/ml
Generic	Butamirate Citrate
Weight	5 mg/ml
Type	Pediatric Drops
Therapeutic Class	Cough suppressant
Manufacturer	ACI Limited
Available Country	Bangladesh
Last Updated:	January 7, 2025 at 1:49 am

Uses

Kofnix Pediatric Drops 5 mg/ml is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection. Kofnix Pediatric Drops 5 mg/ml is also used for pre & post-operative cough sedation in patients who will undergo surgical procedures and bronchoscopy. It can be used in the acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis) etc.

Dosage

Kofnix Pediatric Drops 5 mg/ml dosage

Use in adult: Kofnix Pediatric Drops 5 mg/ml 50 mg tablet: 2-3 tablets daily. Kofnix Pediatric Drops 5 mg/ml syrup: 15 ml 4 times daily. Use in children & adolescents:Kofnix Pediatric Drops 5 mg/ml 50 mg tablet: Adolescent over 12 years old: 1-2 tablets daily. Kofnix Pediatric Drops 5 mg/ml syrup: Children (3-6 yrs): 5 ml 3 times daily. Children (6-12 yrs): 10 ml 3 times daily. Adolescent: 15 ml 3 times daily. Kofnix Pediatric Drops 5 mg/ml pediatric drops: Children ( 2 months- 1 yrs): 0.50 ml 4 times daily. Children (1-3 yrs): 0.75 ml 4 times daily.

Side Effects

Tolerance of Kofnix Pediatric Drops 5 mg/ml is good.Adverse reactions such as rash,nausea,diarrhoea and vertigo have been observed in a few rare cases,resolving after dose reduction or treatment withdrawal.

Precaution

Kofnix Pediatric Drops 5 mg/ml suppresses the cough reflex and therefore the concomitant use with expectorants should be avoided, since it may lead to mucus retention in the airways, which increases the risk of bronchospasm and respiratory infections. If the cough persists for more than 7 days (more than 3 days in children younger than12 years of age) doctor must be consulted.

Interaction

Concomitant use with expectorants should be avoided.

Pregnancy & Breastfeeding use

Kofnix Pediatric Drops 5 mg/ml should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Kofnix Pediatric Drops 5 mg/ml administration during breast feeding should be carefully weighed against the risks.

Contraindication

Hypersensitivity to the active ingredient.

Acute Overdose

Accidental overdose with Kofnix Pediatric Drops 5 mg/ml can cause the following symptoms: drowsiness, nausea, vomiting, diarrhoea, loss of balance and hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives and standard cardio-respiratory resuscitation.

Storage Condition

Keep away from light and moisture, store below 30°C. Keep all the medicines out of the reach of children.

Innovators Monograph